Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rosacea subtypes: a treatment algorithm.

Mark V Dahl1

  • 1Department of Dermatology, Mayo Clinic College of Medicine, Scottsdale, Arizona, USA.

Cutis
|October 27, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Camp Discovery: Changing lives for 25 years.

Journal of the American Academy of Dermatology·2018
Same author

Eosinophil-dependent skin innervation and itching following contact toxicant exposure in mice.

The Journal of allergy and clinical immunology·2014
Same author

Kerion mimicking erosive pustular dermatosis in elderly patients.

Cutis·2013
Same author

Testing lipid levels in granuloma annulare.

Archives of dermatology·2012
Same author

Stem cells and the skin.

Journal of cosmetic dermatology·2012
Same author

Nerve involvement in granuloma annulare.

Journal of cutaneous medicine and surgery·2012

This article outlines rosacea treatments, categorized by its four main subtypes: erythematotelangiectatic, papulopustular, phymatous, and ocular. It reviews evidence-based therapies, acknowledging treatments lacking randomized controlled trial validation.

Area of Science:

  • Dermatology
  • Clinical Medicine

Background:

  • Rosacea is a common chronic inflammatory skin condition.
  • The National Rosacea Society (NRS) classifies rosacea into four primary subtypes: erythematotelangiectatic, papulopustular, phymatous, and ocular.
  • Each subtype presents unique clinical manifestations and may require tailored therapeutic approaches.

Purpose of the Study:

  • To provide a comprehensive overview of rosacea treatments.
  • To categorize treatment strategies according to the established rosacea subtypes.
  • To review therapies supported by randomized controlled trials (RCTs) and acknowledge other effective treatments.

Main Methods:

  • Literature review of treatments for rosacea subtypes.
  • Focus on therapies validated by randomized controlled trials.

Related Experiment Videos

  • Inclusion of recognized treatments not yet validated by double-blind RCTs.

    • Main Results:

    • Erythematotelangiectatic rosacea treatments often include topical agents and laser therapy.
    • Papulopustular rosacea typically responds to topical or oral antibiotics and retinoids.
    • Phymatous and ocular rosacea require specific management strategies, including surgical options and ocular medications, respectively.
    • Sensory rosacea, a recognized subtype, also has specific treatment considerations.

    Conclusions:

    • Treatment selection for rosacea should be guided by the specific subtype and its presenting signs and symptoms.
    • Evidence-based treatments, particularly those from RCTs, form the cornerstone of rosacea management.
    • A broader range of effective therapies exists, even if not all have undergone rigorous RCT validation.